ARCHIVES
2011 – Personalized Medicine of Lung Disease
Advancements being made in Personalized Medicine are ushering in a revolutionary era of patient care, offering researchers, clinicians, and patients themselves an unprecedented chance to comprehend and employ information that promises to optimize preventative and therapeutic care for both the individual and society-at-large.
This Pittsburgh International Lung Conference, held in 2011, focused exclusively on the Personalized Medicine of Lung Disease, describing the present state of knowledge as well as current and potential applications of Personalized Medicine to all Pulmonary Diseases. This conference featured presentations from almost 50 experts in the field.
Following all day 1 speaker sessions, a poster reception was held for researchers to present original findings. The first day concluded with an evening banquet featuring a presentation by William A. Gahl, MD, PhD, Clinical Director of the National Human Genome Research Institute, NIH, DHHS.
Scientific Sessions:
- The First Frontier – COPD
- Beyond Wheezing – Asthma
- Personalizing Acute Lung Injury
- Bench to Bedside: Industry-Academia Happy Hour
- Information – The Key to Personalized Medicine
- Discovering the Gene is Only the Beginning – Lessons from Monogenic Diseases
- Charting Uncharted Land – Interstitial Lung Disease
- Genomics of Pulmonary Hypertension and Sleep
Distinguished speakers included:
- Charles Auffray, PhD | Centre National de la Recherche Scientifique
- Peter J. Barnes, FRS | Imperial College London
- Kathleen C. Barnes, PhD | Johns Hopkins University
- Michael J. Becich, MD, PhD | University of Pittsburgh
- Panayiotis (Takis) Benos, PhD | University of Pittsburgh
- Carrie V. Breton, ScD | University of Southern California
- Juan C. Celedόn, MD, DrPH | Children’s Hospital of Pittsburgh
- Garry Cutting, MD | Johns Hopkins University
- Ramona L. Doyle, MD | Genentech
- William A. Gahl, MD, PhD | National Human Genome Research Institute, NIH, DHHS
- Weiniu Gan, PhD |National Heart, Lung, and Blood Institute, NIH, DHHS
- Joe G.N. Garcia, MD | University of Illinois at Chicago
- Mark T. Gladwin, MD | University of Pittsburgh
- Marc Humbert, MD, PhD | University of South Paris
- Ray Jupp, PhD | Sanofi-Aventis
- Naftali Kaminski, MD | University of Pittsburgh
- Don Kang, PhD | University of Pittsburgh
- James P. Kiley, PhD | National Heart, Lung, and Blood Institute, NIH, DHHS
- George D. Leikauf, PhD | University of Pittsburgh
- James E. Loyd, MD | Vanderbilt University
- Marc S. Malandro, PhD | University of Pittsburgh
- Clay B. Marsh, MD | Ohio State University
- Thomas R. Martin, MD | University of Washington
- Fernando J. Martinez, MD | University of Michigan Health System
- Rasika Mathias, ScD | Johns Hopkins University
- Joachim Müller-Quernheim, MD | Universitäts Klinikum Freiburg
- Allan I. Pack, MD, PhD | University of Pennsylvania School of Medicine
- David H. Perlmutter, MD | University of Pittsburgh
- John Quackenbush, PhD | Harvard School of Public Health
- John J. Reilly, Jr., MD | University of Pittsburgh
- David A. Schwartz, MD, MPH | University of Colorado
- Frank C. Sciurba, MD, FCCP | University of Pittsburgh
- Steven D. Shapiro, MD | University of Pittsburgh
- Edwin K. Silverman, MD, PhD | Harvard Medical School, Brigham and Women’s Hospital
- Avrum Spira, MD, MSc | Boston University School of Medicine
- Jacob I. Sznajder, MD | Feinberg School of Medicine, Northwestern University
- Zsolt Urban, PhD | University of Pittsburgh
- Scott T. Weiss, MD, MS | Harvard Medical School, Brigham and Women’s Hospital
- Sally Wenzel, MD | University of Pittsburgh
- Prescott Woodruff, MD, MPh | University of California, San Francisco
- Ivana V. Yang, PhD | University of Colorado Denver
- Sachin Yende, MD | University of Pittsburgh